Zhejiang Huakang Pharmaceutical Co Ltd (605077)

Currency in CNY
17.57
+0.29(+1.68%)
Closed·
605077 Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
605077 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
17.1817.85
52 wk Range
11.8518.63
Key Statistics
Bid/Ask
17.55 / 17.56
Prev. Close
17.28
Open
17.18
Day's Range
17.18-17.85
52 wk Range
11.85-18.63
Volume
4.93M
Average Volume (3m)
4.4M
1-Year Change
33.92%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
605077 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
20.00
Upside
+13.83%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Buy

Zhejiang Huakang Pharmaceutical Co Ltd Company Profile

Zhejiang Huakang Pharmaceutical Co., Ltd. engages in the research, production, and sale of polyols and starch sugar worldwide. It offers polyols products such as xylitol, is a polyol that occurs naturally regular sugar raise blood sugar levels; sorbitol, is s produced by the catalytic hydrogenation of D-glucose and is available as a free-flowing crystalline powder, and as aqueous solutions; maltitol a bulk sweetener produced from naturally occurring compounds in corn; erythritol, is produced by the enzymatic hydrolysis of starch into glucose, non-caloric, non-hygroscopic excipient with excellent sweet taste and cooling effect; lactitol is produced by hydrogenation of lactose; mannitol is derived from enzymatic hydrolysis of starch; isomalt is produced from sucrose as a raw material and transformed into isomaltulose by sucrose isomerase. In addition, the company offers starch sugar provide high fructose, glucose, maltose syrups, maltodextrin; as well as rare sugar d- xylose, and l-arabinose; and dietary fiber include polydextrose. The company was founded in 2001 and is based in Quzhou, China.

Employees
1350
Market
China

Compare 605077 to Peers and Sector

Metrics to compare
605077
Peers
Sector
Relationship
P/E Ratio
19.3x27.9x12.1x
PEG Ratio
−0.520.100.03
Price/Book
1.6x1.9x1.5x
Price / LTM Sales
1.7x1.7x0.9x
Upside (Analyst Target)
13.8%14.6%16.9%
Fair Value Upside
Unlock20.1%10.6%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 20.00
(+13.83% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.90%
Dividend Yield
2.85%
Industry Median 2.32%
Annualised payout
0.50
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 27, 2025
EPS / Forecast
0.22 / --
Revenue / Forecast
816.55M / --
EPS Revisions
Last 90 days

605077 Income Statement

FAQ

What Stock Exchange Does Zhejiang Huakang Pharmaceutical Co Trade On?

Zhejiang Huakang Pharmaceutical Co is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Zhejiang Huakang Pharmaceutical Co?

The stock symbol for Zhejiang Huakang Pharmaceutical Co is "605077."

What Is the Zhejiang Huakang Pharmaceutical Co Market Cap?

As of today, Zhejiang Huakang Pharmaceutical Co market cap is 5.21B.

What Is Zhejiang Huakang Pharmaceutical Co's Earnings Per Share (TTM)?

The Zhejiang Huakang Pharmaceutical Co EPS (TTM) is 0.90.

From a Technical Analysis Perspective, Is 605077 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Zhejiang Huakang Pharmaceutical Co Stock Split?

Zhejiang Huakang Pharmaceutical Co has split 3 times.

How Many Employees Does Zhejiang Huakang Pharmaceutical Co Have?

Zhejiang Huakang Pharmaceutical Co has 1350 employees.

What is the current trading status of Zhejiang Huakang Pharmaceutical Co (605077)?

As of 17 Aug 2025, Zhejiang Huakang Pharmaceutical Co (605077) is trading at a price of 17.57, with a previous close of 17.28. The stock has fluctuated within a day range of 17.18 to 17.85, while its 52-week range spans from 11.85 to 18.63.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.